Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 17026-42-5
2. (+)-dibenzoyl-d-tartaric Acid
3. Butanedioic Acid, 2,3-bis(benzoyloxy)-, (2s,3s)-
4. (+)-2,3-dibenzoyl-d-tartaric Acid
5. (2s,3s)-2,3-bis(benzoyloxy)succinic Acid
6. D-dibenzoyltartaric Acid
7. (+)-o,o-dibenzoyltartaric Acid
8. (2s,3s)-(+)-dibenzoyltartaric Acid
9. (+)-dibenzoyltartaric Acid
10. Nsc-97424
11. O,o'-dibenzoyl D-tartaric Acid
12. [+]-dibenzoyltartaric Acid
13. (+)-dibenzoyl Tartaric Acid
14. [+]-dibenzoyl Tartaric Acid
15. Tartaric Acid, Dibenzoate, (+)-
16. Mfcd00063222
17. Dibenzoyl D-tartaric Acid
18. D-dibenzoyl Tartaric Acid
19. D-(+)-dibenzoyltartaric Acid
20. Einecs 241-097-1
21. D-(+)-di-o,o-benzoyltartaric Acid
22. Nsc 97424
23. (2s,3s)-2,3-dibenzoyloxybutanedioic Acid
24. Butanedioic Acid, 2,3-bis(benzoyloxy)-, (s-(r*,r*))-
25. (2s,3s)-(+)-dibenzoyl-d-tartaric Acid
26. Schembl223030
27. Chembl522816
28. ( )-dibenzoyl-d-tartaric Acid
29. D-tartaric Acid 2,3-dibenzoate
30. Dtxsid50884953
31. (+)-dibenzoyl-(d)-tartaric Acid
32. Nsc97424
33. Zinc1632636
34. 2-o,3-o-dibenzoyl-d-tartaric Acid
35. (+)-o,o'-dibenzoyl-d-tartaric Acid
36. Akos016842332
37. Ac-3431
38. Am81405
39. Cs-w020547
40. As-31014
41. Bp-12661
42. (+)-dibenzoyl-d-tartaric Acid, Anhydrous
43. D1398
44. D3826
45. 26d425
46. (s-(r*,r*))-2,3-bis(benzoyloxy)succinic Acid
47. Butanedioic Acid,3-bis(benzoyloxy)-, [s-(r*,r*)]-
48. (+)-2,3-dibenzoyl-d-tartaric Acid, >=99.0% (t)
49. (+)-2,3-dibenzoyl-d-tartaric Acid, >=98%, Made From Synthetic Tartaric Acid
| Molecular Weight | 358.3 g/mol |
|---|---|
| Molecular Formula | C18H14O8 |
| XLogP3 | 2.6 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 9 |
| Exact Mass | 358.06886740 g/mol |
| Monoisotopic Mass | 358.06886740 g/mol |
| Topological Polar Surface Area | 127 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 483 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A (+)-Dibenzoyl Tartaric Acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of (+)-Dibenzoyl Tartaric Acid, including repackagers and relabelers. The FDA regulates (+)-Dibenzoyl Tartaric Acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. (+)-Dibenzoyl Tartaric Acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of (+)-Dibenzoyl Tartaric Acid manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A (+)-Dibenzoyl Tartaric Acid supplier is an individual or a company that provides (+)-Dibenzoyl Tartaric Acid active pharmaceutical ingredient (API) or (+)-Dibenzoyl Tartaric Acid finished formulations upon request. The (+)-Dibenzoyl Tartaric Acid suppliers may include (+)-Dibenzoyl Tartaric Acid API manufacturers, exporters, distributors and traders.
click here to find a list of (+)-Dibenzoyl Tartaric Acid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
(+)-Dibenzoyl Tartaric Acid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of (+)-Dibenzoyl Tartaric Acid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right (+)-Dibenzoyl Tartaric Acid GMP manufacturer or (+)-Dibenzoyl Tartaric Acid GMP API supplier for your needs.
A (+)-Dibenzoyl Tartaric Acid CoA (Certificate of Analysis) is a formal document that attests to (+)-Dibenzoyl Tartaric Acid's compliance with (+)-Dibenzoyl Tartaric Acid specifications and serves as a tool for batch-level quality control.
(+)-Dibenzoyl Tartaric Acid CoA mostly includes findings from lab analyses of a specific batch. For each (+)-Dibenzoyl Tartaric Acid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
(+)-Dibenzoyl Tartaric Acid may be tested according to a variety of international standards, such as European Pharmacopoeia ((+)-Dibenzoyl Tartaric Acid EP), (+)-Dibenzoyl Tartaric Acid JP (Japanese Pharmacopeia) and the US Pharmacopoeia ((+)-Dibenzoyl Tartaric Acid USP).
LOOKING FOR A SUPPLIER?
